Literature DB >> 29641381

Anomaly Detection of Electromyographic Signals.

Ahsan Ijaz, Jongeun Choi.   

Abstract

In this paper, we provide a robust framework to detect anomalous electromyographic (EMG) signals and identify contamination types. As a first step for feature selection, optimally selected Lawton wavelets transform is applied. Robust principal component analysis (rPCA) is then performed on these wavelet coefficients to obtain features in a lower dimension. The rPCA based features are used for constructing a self-organizing map (SOM). Finally, hierarchical clustering is applied on the SOM that separates anomalous signals residing in the smaller clusters and breaks them into logical units for contamination identification. The proposed methodology is tested using synthetic and real world EMG signals. The synthetic EMG signals are generated using a heteroscedastic process mimicking desired experimental setups. A sub-part of these synthetic signals is introduced with anomalies. These results are followed with real EMG signals introduced with synthetic anomalies. Finally, a heterogeneous real world data set is used with known quality issues under an unsupervised setting. The framework provides recall of 90% (± 3.3) and precision of 99%(±0.4).

Entities:  

Mesh:

Year:  2018        PMID: 29641381     DOI: 10.1109/TNSRE.2018.2813421

Source DB:  PubMed          Journal:  IEEE Trans Neural Syst Rehabil Eng        ISSN: 1534-4320            Impact factor:   3.802


  2 in total

1.  A warning system for urolithiasis via retrograde intrarenal surgery using machine learning: an experimental study.

Authors:  Jinho Jeong; Kidon Chang; Jisuk Lee; Jongeun Choi
Journal:  BMC Urol       Date:  2022-06-06       Impact factor: 2.090

2.  High-density surface electromyography signals during isometric contractions of elbow muscles of healthy humans.

Authors:  Mónica Rojas-Martínez; Leidy Yanet Serna; Mislav Jordanic; Hamid Reza Marateb; Roberto Merletti; Miguel Ángel Mañanas
Journal:  Sci Data       Date:  2020-11-16       Impact factor: 6.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.